TU Dresden at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

TU Dresden takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on artificial intelligence in oncology, from the ethics and regulation of generative AI to a machine-learning toolbox that estimates multicancer risk from routine clinical data. Other sessions cover DLL3-targeted immunotherapy for hard-to-treat cancers.

OrganizationESMO 2026 Attendance
TU Dresden
Dresden, Germany
tu-dresden.de
University & institute
Public technical university in Dresden, Germany, with a faculty of medicine and a university hospital.
Satellite
Sat Oct 24
19:20–19:40
DLL3: Advancing targeted immunotherapy across difficult-to-treat cancers
Boehringer Ingelheim International GmbH - HER2 and DLL3: Shaping the next generation of targeted cancer therapy
Lung & thoracic cancers
Talk
Sun Oct 25
09:15–09:35
Generative AI ethics
Using Large Language Models (LLM) in multidisciplinary tumor boards: Practical applications and considerations
Abstract
Mon Oct 26
08:30–08:35
Chair
Mon Oct 26
12:00–12:50
What oncologists should know about generative AI to support their clinical practice
with Fondazione IRCCS Istituto Nazionale dei Tumori
Talk
Mon Oct 26
12:30–12:45
What is the regulatory and ethical frame?
What oncologists should know about generative AI to support their clinical practice

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from TU Dresden

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction